CSL Limited trade idea

The healthcare company has been one of the best performers on the ASX 200 for a while, consistently testing 52-week highs over the past few months.

Source: Bloomberg

CSL continues to deliver strong revenue growth, with solid demand for its products. Both plasma products and immunoglobulin are experiencing significant growth and the company continues to look for M&A growth opportunities. Additionally, it is well leveraged to a recovering US economy.

It seems every time the stock consolidates, it’s not long before a breakout comes to fruition. Between August and October, the stock was range bound within the $72-$75 region. Eventually, at the end of October it had enough conviction to knock through that barrier, taking the stock up to the $80 mark.

This level has since presented some challenges for CSL, resulting in a month-long consolidation between $78-$80. A darvis breakout formation now seems to be in play and this is could take CSL another leg higher. The key will be for CSL to close above $80.44 today, which is the October high. This would effectively be a darvis breakout. Traders could potentially buy the stock above $80.44, with stops placed in the $77.50 region. Given this is unchartered territory for the stock, targets will have to be assessed on the momentum of the trade.

Click to enlarge

IGA, may distribute information/research produced by its respective foreign marketing partners within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.

This information/research prepared by IGA or IGA Group is intended for general circulation. It does not take into account the specific investment objectives, financial situation or particular needs of any particular person. You should take into account your specific investment objectives, financial situation or particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. In addition to the disclaimer above, the information does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any views and opinions expressed may be changed without an update.

See important Research Disclaimer.